HCPCS Level II code A9595 identifies piflufolastat F-18, a diagnostic radiopharmaceutical supplied in 1 millicurie units for PET imaging. This code matters nationally because it standardizes billing for an emerging PET tracer used in diagnostic imaging, affecting provider billing, payer coverage decisions, and access to specialty imaging services. Clear coding supports accurate claims submission and reimbursement for high-cost radiopharmaceuticals.

Key payers referenced include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find national benchmarks for coverage and reimbursement practices, an overview of payer policy considerations, and clinical context about the service type and typical site of service. The publication outlines how the code is used in claims for outpatient imaging centers and hospital radiology departments and highlights common billing issues to monitor, such as unit reporting and documentation needs.

The analysis supplies actionable reference material: code definition and clinical use, payer coverage landscape, common administrative challenges, and pointers to relevant policy updates. Data limitations where input is incomplete are noted as "Data not available in the input." The content is intended for billing professionals, radiology administrators, and policy analysts seeking a concise national view of HCPCS Level II code A9595 and its role in PET imaging workflows.